首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >CD45-deficient severe combined immunodeficiency caused by uniparental disomy
【24h】

CD45-deficient severe combined immunodeficiency caused by uniparental disomy

机译:单亲二体性切开引起的CD45缺陷型严重联合免疫缺陷

获取原文
获取原文并翻译 | 示例
       

摘要

Analysis of the molecular etiologies of SCID has led to important insights into the control of immune cell development. Most cases of SCID result from either X-linked or autosomal recessive inheritance of mutations in a known causative gene. However, in some cases, the molecular etiology remains unclear. To identify the cause of SCID in a patient known to lack the protein-tyrosine phosphatase CD45, we used SNP arrays and whole-exome sequencing. The patient's mother was heterozygous for an inactivating mutation in CD45 but the paternal alleles exhibited no detectable mutations. The patient exhibited a single CD45 mutation identical to the maternal allele. Patient SNP array analysis revealed no change in copy number but loss of heterozygosity for the entire length of chromosome 1 (Chr1), indicating that disease was caused by uniparental disomy (UPD) with isodisomy of the entire maternal Chr1 bearing the mutant CD45 allele. Nonlymphoid blood cells and other meso-derm- and ectoderm-derived tissues retained UPD of the entire maternal Chr1 in this patient, who had undergone successful bone marrow transplantation. Exome sequencing revealed mutations in seven additional genes bearing nonsynonymous SNPs predicted to have deleterious effects. These findings are unique iri representing a reported case of SCID caused by UPD and suggest UPD should be considered in SCID and other recessive disorders, especially when the patient appears homozygous for an abnormal gene found in only one parent. Evaluation for alterations in other genes affected by UPD should also be considered in such cases.
机译:对SCID分子病因学的分析已导致对免疫细胞发育控制的重要见解。 SCID的大多数情况是由于已知病因基因中突变的X连锁或常染色体隐性遗传所致。但是,在某些情况下,分子病因仍不清楚。为了确定已知缺乏蛋白酪氨酸磷酸酶CD45的患者SCID的原因,我们使用了SNP阵列和全外显子组测序。患者的母亲是CD45失活突变的杂合子,但父亲等位基因未显示出可检测到的突变。该患者表现出与母亲等位基因相同的单个CD45突变。患者SNP阵列分析显示,在第1号染色体(Chr1)的整个长度上拷贝数没有变化,但杂合性丧失,表明该疾病是由单亲二体性(UPD)引起的,整个母体Chr1带有等位基因携带突变CD45等位基因。非淋巴血细胞以及其他中胚层和外胚层来源的组织保留了该患者中成功进行了骨髓移植的整个母体Chr1的UPD。外显子组测序揭示了另外七个带有非同义SNP的基因的突变,这些基因预计具有有害作用。这些发现是唯一的虹膜,代表由UPD引起的SCID报道病例,并建议在SCID和其他隐性疾病中应考虑使用UPD,尤其是当患者出现纯合子时,仅在一个亲本中发现异常基因。在这种情况下,还应考虑评估受UPD影响的其他基因的改变。

著录项

  • 来源
  • 作者单位

    Department of Pediatrics Duke University Medical Center, Durham, NC 27710;

    Department of Pediatrics Duke University Medical Center, Durham, NC 27710,Department of Immunology, Duke University Medical Center, Durham, NC 27710;

    Cancer Genome Institute, Fox Chase Cancer Center, Philadelphia, PA 19111,Cancer Biology Program, Philadelphia, PA 19111;

    Cancer Biology Program, Philadelphia, PA 19111;

    Cancer Genome Institute, Fox Chase Cancer Center, Philadelphia, PA 19111;

    Cancer Genome Institute, Fox Chase Cancer Center, Philadelphia, PA 19111;

    Developmental Therapeutics Program Philadelphia, PA 19111;

    Department of Pediatrics Duke University Medical Center, Durham, NC 27710;

    Department of Pediatrics Duke University Medical Center, Durham, NC 27710;

    Developmental Therapeutics Program Philadelphia, PA 19111;

    Cancer Biology Program, Philadelphia, PA 19111,Blood Cell Development and Cancer Keystone, Immune Cell Development and Host Defense Program Philadelphia, PA 19111;

    Department of Pediatrics Duke University Medical Center, Durham, NC 27710,Department of Immunology, Duke University Medical Center, Durham, NC 27710;

    Blood Cell Development and Cancer Keystone, Immune Cell Development and Host Defense Program Philadelphia, PA 19111;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    T lymphocyte; T cell receptor; signaling;

    机译:T淋巴细胞;T细胞受体;发信号;
  • 入库时间 2022-08-18 00:40:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号